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BACILLUS CALMETTE-GUERIN (BCG) LYMPHADENITIS- CHANGING 
TRENDS AND MANAGEMENT 
Zafar Nazir, Saqib Hamid Qazi 
St'ftion of l'ediatrir Suq!;cr~. Depa1·tment of Surgery. The :\!!)1 Khan l"nhersity 1-lospit:d, Karachi, Pakistan 
Background: Haci!lus Ca!mctte-GuCrin (BCG) vaccination is performed a-; a part of c:-..pandcJ 
Programme of !nlmunization (!·:PI). Suppurative ly'!llphadcnitis is the common C\)11\[Jlication of B('(i 
\accinaliOil 'J'hc optillllllll trL'<Itment f{x this complication is debated. Methods: All Cii.'>CS orB('() 
l:mphtJdenlli:, presenting to pediatric surgical ~crvicc over a 17-:year study rcriod \\·Cre rcviC\\t'd to 
dl'lcrmine tlh: <lptimum treatment f{)r this problem. Results: Sixty children \-vcre referred for the 
m~m~tgcm~nt of BCCr lyrnphadenitis during the study period. ~1ost patient~ (n 43) prc<;enkd during 
I 9SX ~md 1990. Children \Verc healthy and received BC(i (Pasteur strain) \ilCcination at LPl during 
lir.'>t::: month-; uf lilC. Initially <til the patients received medical treiltment \Vith anti-tuberculous dr11gs 
for one to nine months. l·"ifty-t\VO children \vho presented with large(-· 3cm) fluctuant lymph node~. 
required a · ... urg.ic<tl procedure to avoid spontnneous rapture and sinu:; formation (CJroup A), whereas 
medical trt.'i.ltnrcnt was eft"cctivc in live out of eight patients presenting with small ( I Clll) nmks 
((iruup B). Conclusions: Medical treatment with antituhercui<H!s drugs is not dlCctivc totiT<lt HC(I 
l~ mphadcnitis, \\'hl'll the involved lymph nodes arc around 1.0 cm and have developed lluctuatiorr tllld 
inthun1nation of ovcc lying skin. 
1\.cy\vords: Vaecindtion. BC(i vaccine. Lymph node, Lymphadenitis 
1\TRODl'('TJON 
I~;Jcilluc; Calllll'tlc-Ciucrin (HCC.i) is a live attenuated 
\;IL·ciJJC dct·in~d IJ·oJll a <.;Jrain of M_ycobactcrium bovis. 
I ill- n·orld health nrgani/.ation (\VHO) has 
1 ccllllllllCrllkd H( ·c; vaccinati(m as a part of the global 
..._·\l';llllkd rrogram ftlr irnmuni/<1tio11 (EPI). The 
l·t'liL·~~c~ of eurrcml~ available RCCJ vaccines ranges 
f1·,\lll (J(J ltl 90° o.J. 'B( ·c; vaccine i<.; a sal\.> vaccine, but a 
llllllllk'r or complications such <.is localil'cd ulceration, 
rc~innal 1~ mphadcnitis, ostcomyeli tis, lupoid reactions. 
L'L'/Lill:l \'t!ccin:ttum, !Jypcrtrophic scar;, and keloid 
tnrmdli\lll. JisscmintJtcd infection and death fOllow 
1 ill'Cinatillll. H· ThL' incidence of regional suppurative 
I) lllph:ILknitis r<~ngcs from 0. l to 38 per 1000. 1·' ~ ·rherc 
;qlpc;w., to be no agreement on the trL'atment of this 
rl'Llli\ch ct1111mun complication. Opinions differ 
11 idL·h. lhm1 no treatment tn surgical drainage to 
:Jdill.llli...,tration of antitul1L'ITtilous drugs. l"hc beneficial 
\..·rtl·(h ul· the;-,c thcrapic" are contnwa~ial. 2 ; The 
lll'l'"<.:tlt report dt:'-icribes •.,i'\t) patients \\'ho developed 
rc~'.illll,ll I~ mphadcniti . .:., following BCCI vaccination and 
\\l't.l' r·l·ll'ncd to pediatric surgical service at the Aga 
kll<ttl ! 'nivl'r'>ity hospital (i\KUII), KarachL from July 
I ()Sh tu June :::'003. The emphasis is un ctlicacy of 
Llii'kTcrrt tlll·rapcutic <rpprot!che-> 
.\1.\ITRIAL AND !\1ETHODS 
~kdice~l records were reviewed t(>r year of 
pl'l'SC!l[<llion. age at YL!CCination and f)rt'SentatiOil tO 
-\Kl :11. :>o. pl<tce llf v<tccinmions, interval between 
\ a.::ertlalt\111'> and dn·dopment of lymph<!dcnitis, 
cli11icrl findings on physic:1l examinations, 
lwrncltologiccrl. micr<Jhiological and hist~)pathologica 1 
d·.rta. chest r~tdiograph.'>, T!Tiltnrcnt and outcome. 
I(, 
Fifty-two children underwent a surgical pn1ccdure 
(Group A) whereas eight patients rcceiVL'd medical 
treatment only (Ciroup H). Indication" of ;-,urger}-
include fitilure of !lledical treatment large ( .\.0 em) 
lymph nodes, and development of llucttr<ltion cmd 
intlmmnation of overlying skir1. 'l·hL surgie<tl procedure 
was perrormed under genen1l an;Jesthesla. 
Lxeochleation of all the necrotic tissue and nci-.,i(m ol 
enlarged lymph nodes \\<IS perlt1rmed through l.l skin 
crease incision. Aller hcmost;,rsls the wound wa~ clo~cd 
in subcuticular L1shion using 5/0 Vlcryl suture :1Her 
leaving a Penrose dmin. /\. pressure dt\'c,-.,ing \\'<1'> 
applied ft)r 48- hours. All the surgical spCcimcn) wen: 
sent 10 microbiology: for a routine and AFB culture nn 
Li)\\'cnstcin Jensen crgar, and lttr historttthnlogical 
evaluation. 
RESULTS 
The number of patients having BC(i 1: mrhadcnttis hilS 
decreased after 1991. Forty-three patients (71 o,-;)J 
presented during !988 and !990 (Figure 1). Most 
patienl.s were full-term (n·~57) and none had clinlctll 
evidence of immune deficiency. Their ;1ges ranged 
from 2_5 months to 6 )'t.\lrs (mean 7 month.'>). and tlk' 
male to ICma!e ratio W<l'i 2.9: l The patients rcui\'ed 
vaccination within first two months of lite at !·PI 
centers with Pasteur strain of BCCi vacernc 
Lymphadenitis developed within 6-months in 55 
pnticnts (9:?<%), wherca:-; five children developed 
lymphadenopathy l to 5 years aner the vaccination. 
The localization of lymphadenopathy varied according 
to vaccination site~ left axilla (n 57). leH 
suprnclavicular region (n :::') and right inguinal region 
(n=l). Three pmicnts \VCIT anelllic (hclllatocrit 30°-o} 
and two had raised FSR ( -:::'0 mm hi') Chest 
1 
radiog.raphs available in ~.'i patients did not revealed 
ahnnrnl<dit) The si;rc of enlarged lymph nodes varied 
tt·om l jem ttl )_Ocm (mean ]_5em) .. At the time of 
rcktT<tL all the patient':> were receiving medical 
ll-ccttmctll; i~tmiclLili (n~-5~L ribmpicin (n-- 50), and 
lT) tilwlllycin {n'"'8) for one to nine-months (mean 3-
nlonth.-;) and ~0 patient.-; had developed discharging 
~imh ful!mvmg needle aspiration of fluctuant lymph 
node~. I he results are summarized in Figure 2 
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Figure I: BCG lymphadenitis at AKUH from 
1986-2003 
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Figure 2: Management of BCG lymphadenitis at 
AKUH 
Group A 
Fifty-two patients who presented with large fluctuant 
lymph nodes (--3.0 em) with overlying skin change and 
discharging sinus (n=20) underwent a surgical 
procedure (Figure 3). Histopathological evaluation of 
extirpated nodes showed caseous necrosis and 
granuloma fotmation, a finding consistent with 
tuberculosis. Microbiology revealed growth of 
mycobacterium bovis (n=2), staphylococcus aureus 
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(n-A), staphyluuJecus cpidcrmatillc-. (n 3), p-..;cudtll\1-
onas (n~-l) and Kkbc-.ielln :-.pp. (n 1)_ Post llJ1LT<ttiVL'I;. 
all the patienis \·VCn: prescribed antitubcrculnus 
tre8tmcnt tbr 6 \\·ccks. Nilll' paticttl\ though ;!Lh tc,cd d1d 
not take cmti-tubcrculosis drug~ in pustupcn\lnc pntud 
for various reason.-..; 1\vn patiL·nh had supcrtl..:icd 
wound infections. and three dnclnpcd scrollla. All 
patients recovered and did not shlmcd evidence (lt 
lymphadenitis or sy,')temic tulx:rculo:-;is on 6-l X month-" 
follmv-up. 
·····~ 
Figure J: Suppuratiw B('(; 1:-.mphadt"nitis in ngh1:1\i!l:lr~ 
region. The I~ mph nod!' nH·asun·-~ 5 nn in diameltr, :utd i~ 
fluctuant in rtntrt and thr 1n·rrl~·ing skin is inllanu:d 
Group B 
Eight patients received medical lrcclt!llcnt only. At LilL' 
time of referral, these patients had smaller I; mph node~ 
C- \.Scm). and the overlying skin was normal. hvc 
patients showed resolution of lymphadcnorcnh: dlicr (, 
month') of treatment. Three patiL'nlc-. did nnt n:spn11d. 
continued to have progressive disease. and undcm·cnt 
surgery at other medical facility . 
DISCUSSION 
Intradermal vaccinations with BCG give rise to <l 
classic primary complex that consists of a cutanctJLL'> 
nodule at t-he site of injection and swelling of th.:-
regional lymph nodes. Thi,') is usually self- limiting and 
requires no treatment. Hovvevcr, in a small propotiion 
of subjects this reaction to BCG vaccine is excessive 
and results in suppurative lymphadenitis. BCCi 
lymphadenitis is commonly observed nvo to eight 
weeks following vaccination, although there can be a 
delay up to 8 months or even more as seen in this 
study.u. 7· g The involved nodes are usually ipsilateral to 
the vaccination site. A number of t~1ctors SLlch as age of 
the child, technique of vaccination. the BCG strain. the 
dose, potency, viability and immunogenicity of the 
vaccine and prior exposure to mycobacterial antigen arc 
implicated in the pathogenesis of lymphadenitis. 1 -,_x 
The younger children are more commonly atlccted. 
The studies on these children have failed to 
demonstrate significant nutritional or immune 
deficiency. 1 Epidemics of BCG lymphadenitis were 
l"L'pnneU in many countric~ Juring !9X8 to ! 990 as seen 
in thi'i :-.tudy. 1 "-' 1 Analysis of all tl1esc epidemics has 
r·e\·calcd that BCCi lymphadenitis is an exaggermed 
r·c...,ponse t\1 more immunogenic vcrccinc.s. All of these 
L')lidcmics llccurred \\'llL'tl a 8CCJ vaccine containing 
111\ll"L' llll!llllllO!.!Cnic strain was introduced m the 
rnmwnrt.tllron ~schedulc:.L"-tt The maintt:mmce of 
ditfercnt LJhomtorie . ..., rm the manu!~1cturing of BCG 
\ttccinc h<ts resulted in 01 variety of BC(J strains with 
...,]rghtl: Jit't'cring geno and phen01ypic properties. The 
cellular contpont:nts or a particular vaccine not only 
intlucnce t]IL' outcome of innnuni;:ation but also post 
\dCcrrratJon conlplications. 1 _~, ·rhus the protective 
pr·opcrt!cs and advcr.-.e effects cau~ed by different BCCi 
'>!rains mt~\ \ary. 1 Moreover, inappropriate storage, 
\\ mng method of administratinn of vaccmc and 
'>l'COildary lllVaSJO!l Of immunizi.ltiOil site by the 
p)Pgcnlc or:,',;mJsms llltlY contribute to the Lk·ve!opment 
ul' HCCi ly 111phadcnitis in the dcvt'loping countries. 
!'he reptJrtcd lrc<ltment of BC(J lymphadenitis 
\I!I"IC'i ti·om doing nothin~ to medical treatment. or 
'>Urgicll C\.Ci':iion <.;f involv~d lymph nodc::._ 1> 1·1 BCG is 
... cn:-lli\L' tn isnniov.id. ri!~m1pieine and erythromycin ;n 
l'!lru. but the trL'<tllllcnt uf BCG lymrhadcnitis with 
these agenh is not ellcctivc, once the lymph nodes has 
rL'<Jchcd a certain si;e ( -3.0 em), and has developed 
!luctuation and in!lnnmcltion of overlying sh:in_··-~-~~ 
Medical trentment ma\· be c!fcctive in earlv sta!!,e of the 
I. ' 1" I,,,\\'' I . I j' I ,,· ~~ . ,, I' llscac;e_ · !t 1 a rc t!psc rak o '-t /o anl nst\: o 
Jl..,tulation. needle aspiration of caseating lymph nodes 
1s not un alternative to surgcry. 111. 1' Surgical excision is 
a trcmment of choice !(Jr tluctu<mt. enlarged lymph 
tmdc_.., where the in!lmlm;ttOr) process has involved or 
pL'rf(mited the skin.-~- 111 It can prevent development of 
ptT_..,i'-\ll:nt discharging .;;inus. It is imp011;mt to e:-.:cise all 
m·cL'ssible nodes \\-\JLmd ht·aling, after excision is 
ll..,utdl: c_\cclknt. A Penrose drain in the residual space 
at'llT the c.\cision of a:--:illary lymph nodes can prevent 
\l'Hlln<l. AlthOltgh recommended, postoperative anti-
tuberculosis therapy seem.'> to be unneccssary. 11 ' Nine 
p<ltients in thic; series who did not take anti-tuberculosis 
drug,s postoperatively had an ttrH.'Vcnt!'ul healing and 
outcome. A prophy·lactic dose of broad-spectrum 
antibiotic may prevent \VOLmd infections a.':'i .':lignificant 
number or pntients in this series have grown py--ogenic 
orgc:mism h\1!11 the excised lymph nodes. 
!n conclusion, suppurative lymphadenitis i.':l a 
common complication of BCG vaccination and is 
prnbably !S secondat)' to introduction of more 
immunogenic vaccines. Medical treatment is usually 
ineffective once the enlarged lymph nodes have 
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dev-eloped tluctuation and inllammatiun ot· over!~ ing 
skin. It i::; important to develop unit(mn S):-,tem to 
standardize RCG vaccines and cxerci:.e re:-,train in 
switching the preparations of RCCr \'accine in the 
developing countries, as this could intlucncc the 
compliance to EPI prog_r<lmmes in the:,c countrics_ 1 ~ 
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